Literature DB >> 9422589

Identification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide.

A G Allen1, T Isobe, D J Maskell.   

Abstract

A DNA locus from Bordetella pertussis capable of reconstituting lipopolysaccharide (LPS) O-antigen biosynthesis in Salmonella typhimurium SL3789 (rfaF511) has been isolated, by using selection with the antibiotic novobiocin. DNA within the locus encodes a protein with amino acid sequence similarity to heptosyltransferase II, encoded by waaF (previously rfaF) in other gram-negative bacteria. Mutation of this gene in B. pertussis, Bordetella parapertussis, and Bordetella bronchiseptica by allelic exchange generated bacteria with deep rough LPS phenotypes consistent with the proposed function of the gene as an inner core heptosyltransferase. These are the first LPS mutants generated in B. parapertussis and B. bronchiseptica and the first deep rough mutants of any of the bordetellae.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422589      PMCID: PMC106845          DOI: 10.1128/JB.180.1.35-40.1998

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  44 in total

1.  Pertussis: the trials and tribulations of old and new pertussis vaccines.

Authors:  J D Cherry
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Moredun Bordetella Medium, an improved selective medium for isolation of Bordetella parapertussis.

Authors:  K M Connor; J F Porter; M M Quirie; W Donachie
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  A porcine model for the evaluation of virulence of Bordetella bronchiseptica.

Authors:  M R Ackermann; K B Register; C Gentry-Weeks; S M Gwaltney; T Magyar
Journal:  J Comp Pathol       Date:  1997-01       Impact factor: 1.311

Review 4.  Historical review of pertussis and the classical vaccine.

Authors:  J D Cherry
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

5.  The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship.

Authors:  A van der Zee; H Groenendijk; M Peeters; F R Mooi
Journal:  Int J Syst Bacteriol       Date:  1996-07

6.  Economic impact of pertussis.

Authors:  M E Pichichero; J Treanor
Journal:  Arch Pediatr Adolesc Med       Date:  1997-01

Review 7.  Bacterial polysaccharide synthesis and gene nomenclature.

Authors:  P R Reeves; M Hobbs; M A Valvano; M Skurnik; C Whitfield; D Coplin; N Kido; J Klena; D Maskell; C R Raetz; P D Rick
Journal:  Trends Microbiol       Date:  1996-12       Impact factor: 17.079

8.  Mutational analysis and properties of the msbA gene of Escherichia coli, coding for an essential ABC family transporter.

Authors:  A Polissi; C Georgopoulos
Journal:  Mol Microbiol       Date:  1996-06       Impact factor: 3.501

9.  The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis.

Authors:  A Allen; D Maskell
Journal:  Mol Microbiol       Date:  1996-01       Impact factor: 3.501

Review 10.  Treatment of acute bronchitis in adults without underlying lung disease.

Authors:  D N MacKay
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

View more
  14 in total

1.  Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence.

Authors:  N P West; H Jungnitz; J T Fitter; J D McArthur; C A Guzmán; M J Walker
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

Review 2.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent.

Authors:  Neil J Oldfield; Anthony P Moran; Lorna A Millar; Martina M Prendergast; Julian M Ketley
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

4.  Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

Authors:  E T Harvill; A Preston; P A Cotter; A G Allen; D J Maskell; J F Miller
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities.

Authors:  Lyndsay M Schaeffer; Francis X McCormack; Huixing Wu; Alison A Weiss
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

6.  OpsX from Haemophilus influenzae represents a novel type of heptosyltransferase I in lipopolysaccharide biosynthesis.

Authors:  Sabine Gronow; Werner Brabetz; Buko Lindner; Helmut Brade
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

7.  Comparison of bipA alleles within and across Bordetella species.

Authors:  Bryna Fuchslocher; Laura L Millar; Peggy A Cotter
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

8.  Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity.

Authors:  Jeroen Geurtsen; Monika Dzieciatkowska; Liana Steeghs; Hendrik-Jan Hamstra; Johanna Boleij; Kelly Broen; Grietsje Akkerman; Hassan El Hassan; Jianjun Li; James C Richards; Jan Tommassen; Peter van der Ley
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

9.  Role of antibodies in immunity to Bordetella infections.

Authors:  Girish S Kirimanjeswara; Paul B Mann; Eric T Harvill
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Characterization of a WaaF (RfaF) homolog expressed by Haemophilus ducreyi.

Authors:  B A Bauer; S R Lumbley; E J Hansen
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.